Citicoline Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 250 mg,500 mg
Reference Brands:
Category:
Antipsychotropic Drugs
CITICOLINE belongs to a group of medications called ‘psychostimulants’ used to treat stroke, head trauma or injury, Alzheimer’s disease, Parkinson’s disease, and glaucoma. A stroke occurs due to insufficient blood supply to the brain. Alzheimer’s disease is a progressive age-related memory loss. Parkinson’s disease is a progressive brain disorder that affects movement. Glaucoma is an eye problem that occurs due to damage to the optic nerve, responsible for vision.
Citicoline Tablets is available in Tablets
and strengths such as 250 mg,500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Citicoline Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Citicoline Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
-
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing